Our Story

Tyler Group International was founded on a simple but powerful truth: exceptional breakthroughs in rare disease and emerging biotech can only happen when exceptional humans lead the way.

In the rare disease and emerging biotech sectors, leadership is the critical differentiator between organizations that merely survive and those that truly transform patient lives. Through years of placing executives in this specialized space, a consistent pattern was observed: traditional executive search often delivered technically qualified candidates, but missed the intangible qualities that separated good leaders from exceptional ones.

The rare disease and biotech sectors face unique challenges that demand distinctive leadership attributes. These challenges require leaders who bring more than impressive resumes - they demand exceptional humans who combine scientific credibility with authentic patient focus, business acumen and the ability to inspire teams through uncertain journeys.

When exceptional organizations find exceptional humans, patients' lives change. That's the mission that drives everything we do.